Cns Pharmaceuticals

(NASDAQ) CNSP

Current Price$2.31

Market Cap$1.88M

Since IPO (2019)-100%

5 Year-100%

1 Year-82%

1 Month+2%

Cns Pharmaceuticals Financials at a Glance

Market Cap

$1.88M

Revenue (TTM)

$0.00

Net Income (TTM)

$15.85M

EPS (TTM)

$-41.26

P/E Ratio

-0.06

Dividend

$0.00

Beta (Volatility)

0.70 (Low)

Dividend

$0.00

Beta (Volatility)

0.70 (Low)

Price

$2.31

Volume

12,377.2

Open

$2.27

Price

$2.31

Volume

12,377.2

Open

$2.27

Previous Close

$2.31

Daily Range

$2.27 - $2.37

52-Week Range

$1.90 - $34.80

Dividend

$0.00

Beta (Volatility)

0.70 (Low)

Price

$2.31

Volume

12,377.2

Open

$2.27

Previous Close

$2.31

Daily Range

$2.27 - $2.37

52-Week Range

$1.90 - $34.80

CNSP News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Cns Pharmaceuticals

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

John M. Climaco

Website

www.cnspharma.com

Headquarters

Houston, TX 77027, US

CNSP Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

-296%

Return on Capital

-4%

Return on Assets

-2%

Earnings Yield

-16.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.88M

Shares Outstanding

811.40K

Volume

12.38K

Avg. Volume

31.14K

Financials (TTM)

Gross Profit

$0.00

Operating Income

$15.99M

EBITDA

$15.83M

Operating Cash Flow

$13.81M

Capital Expenditure

$18.18K

Free Cash Flow

$13.83M

Cash & ST Invst.

$7.20M

Total Debt

$328.57K

Cns Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$2.90K

+394.2%

Gross Margin

0.00%

N/A

Market Cap

$1.88M

N/A

Market Cap/Employee

$468.82K

N/A

Employees

N/A

Net Income

$5.96M

-87.5%

EBITDA

$5.95M

-87.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$6.87M

+12.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$328.57K

+0.8%

Return on Assets

-1.84%

N/A

Return on Invested Capital

-3.53%

N/A

Free Cash Flow

$3.07M

+43.9%

Operating Cash Flow

$3.05M

+44.2%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SXTP60 Degrees Pharmaceuticals, Inc.

SXTP60 Degrees Pharmaceuticals, Inc.$1.66+5.06%

NLSPNLS Pharmaceutics AG

NLSPNLS Pharmaceutics AG$2.91-12.61%

WINTWindtree Therapeutics, Inc.

WINTWindtree Therapeutics, Inc.$0.02-20.00%

GRIGRI Bio, Inc.

GRIGRI Bio, Inc.$2.18+0.00%

SNGXSoligenix, Inc.

SNGXSoligenix, Inc.$0.34+0.00%

ENSCEnsysce Biosciences, Inc.

ENSCEnsysce Biosciences, Inc.$0.39+4.68%

SILOSilo Pharma, Inc.

SILOSilo Pharma, Inc.$0.45+2.38%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

NOKNokia

NOKNokia$13.30+0.03%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.07+0.05%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.70+0.01%

SOFISoFi Technologies

SOFISoFi Technologies$16.43+0.02%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$65.30+0.03%

NIONio

NIONio$5.91-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.22-0.03%

Questions About CNSP

What is the current price of Cns Pharmaceuticals?

Cns Pharmaceuticals is trading at $2.31 per share.

What is the 52-week range for Cns Pharmaceuticals?

Over the past 52 weeks, Cns Pharmaceuticals has traded between $1.90 and $34.80.

How much debt does Cns Pharmaceuticals have?

As of the most recent reporting period, Cns Pharmaceuticals reported total debt of $328,571.

How much cash does Cns Pharmaceuticals have on hand?

Cns Pharmaceuticals reported $7.20M in cash and cash equivalents in its most recent financial results.

What is Cns Pharmaceuticals’s dividend yield?

Cns Pharmaceuticals does not currently have a dividend yield.

Cns Pharmaceuticals

Cns Pharmaceuticals Financials at a Glance

CNSP News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Cns Pharmaceuticals

CNSP Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Cns Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CNSP

What is the current price of Cns Pharmaceuticals?

What is the 52-week range for Cns Pharmaceuticals?

How much debt does Cns Pharmaceuticals have?

How much cash does Cns Pharmaceuticals have on hand?

What is Cns Pharmaceuticals’s dividend yield?

Premium Investing Services